RecruitingNot ApplicableNCT07384897

Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease


Sponsor

Université Catholique de Louvain

Enrollment

425 participants

Start Date

Feb 17, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to better understand the role of immune system cells in lung diseases such as lung cancer, sarcoidosis, and chronic obstructive pulmonary disease (COPD). The investigators are studying how these immune cells can sometimes help the body defend itself, but in other cases may contribute to cancer growth or long-term lung inflammation. Although recent treatments like immunotherapy have improved cancer care, only a small proportion of patients currently benefit from these therapies. One goal of this research is to understand why some patients do not respond or develop resistance to treatment. The knowledge gained from this study may help researchers develop more effective and personalized treatments for people with lung diseases in the future.


Eligibility

Max Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating the role of immune cells in lung cancer and chronic inflammatory lung diseases like COPD and sarcoidosis. Researchers will collect and analyze immune cells from patients to better understand how these diseases develop and to potentially improve immunotherapy treatments. **You may be eligible if...** - You have been diagnosed with lung cancer or have precancerous lung lesions - You have a chronic inflammatory lung disease (COPD or sarcoidosis) and have not yet started treatment - You are a healthy adult with no known lung disease (for the control group) - You are a child weighing at least 10 kg with a genetic condition called chronic granulomatous disease (CGD) - You are an adult scheduled for orthopedic surgery that involves bone marrow collection **You may NOT be eligible if...** - You take systemic corticosteroids at a dose higher than 10 mg/day of prednisone - You have an active infection at the time of enrollment - You are unable or unwilling to give informed consent - You have a chronic inflammatory lung disease currently being treated with immune-suppressing medications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPeripheral Blood Collection for Immune Profiling

Participants provide biological samples for immune profiling and translational research. Samples include peripheral blood and, when available from routine clinical care, additional specimens such as tumor tissue or rlymph node, bone marrow. No experimental treatments are given. Collected samples are analyzed to characterize immune cell populations and their functional and molecular features, with the aim of studying immune mechanisms involved in lung cancer, sarcoidosis, and COPD, as well as factors associated with disease progression and treatment response. All medical care and treatment decisions remain independent of study participation.


Locations(1)

Cliniques universitaires saint Luc

Brussels, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07384897


Related Trials